Marble Harbor Investment Counsel’s CVS Health CVS Stock Holding History

Marble Harbor Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,185	Closed	-$254K	–	206
2024 Q1	$254K	Sell	3,185 -1,000	-24%	-$76.4K	0.03%	186
2023 Q4	$330K	Hold	4,185	–	–	0.04%	158
2023 Q3	$292K	Hold	4,185	–	–	0.04%	160
2023 Q2	$289K	Hold	4,185	–	–	0.04%	162
2023 Q1	$311K	Hold	4,185	–	–	0.04%	158
2022 Q4	$390K	Hold	4,185	–	–	0.05%	137
2022 Q3	$399K	Hold	4,185	–	–	0.06%	130
2022 Q2	$388K	Hold	4,185	–	–	0.06%	135
2022 Q1	$424K	Hold	4,185	–	–	0.05%	136
2021 Q4	$432K	Buy	4,185 +1,700	+68%	+$157K	0.05%	137
2021 Q3	$211K	Hold	2,485	–	–	0.03%	185
2021 Q2	$207K	Buy	+2,485	New	+$204K	0.03%	192
2020 Q3	–	Sell	-3,406	Closed	-$221K	–	166
2020 Q2	$221K	Hold	3,406	–	–	0.04%	147
2020 Q1	$202K	Buy	+3,406	New	+$227K	0.04%	146
2017 Q4	–	Sell	-2,921	Closed	-$238K	–	158
2017 Q3	$238K	Buy	+2,921	New	+$231K	0.05%	149
2013 Q3	–	Sell	-5,318	Closed	-$304K	–	134
2013 Q2	$304K	Buy	+5,318	New	+$308K	0.09%	106

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Marble Harbor Investment Counsel's CVS Position: Q2 2024 in Review

Marble Harbor Investment Counsel sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,185 shares — an estimated $254K sold.

Marble Harbor Investment Counsel first reported a position in CVS in Q2 2013 and held it in 16 quarters. The position peaked at $432K in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Marble Harbor Investment Counsel reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Marble Harbor Investment Counsel sold 3,185 CVS Health shares in Q2 2024, an estimated $254K.
Marble Harbor Investment Counsel first reported a position in CVS Health in Q2 2013 and held it in 16 quarters.
Marble Harbor Investment Counsel's CVS Health position peaked at $432K in Q4 2021.
1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Marble Harbor Investment Counsel's 13F filing for Q2 2024, filed 9 Aug 2024.